Seagen (SGEN) Gets Positive CHMP Opinion for Bladder Cancer Drug

Published on December 20, 2021

The CHMP gives a positive opinion on, and recommends approval to Seagen's (SGEN) Padcev as a monotherapy for treating adult patients with locally advanced/metastatic urothelial cancer.

Continue reading on website
Other news

How Success Happened for Sean Moriarty, CEO of Leaf Group

December 20, 2021
Since the early days of the internet, Sean Moriarty has led teams that have dramatically changed how we buy goods and services online.

Target (TGT) Unveils Latest Deals For Last-Minute Shopping

December 20, 2021
Target (TGT) announces last-minute deals so that late-start shoppers can also avail the essentials and gifts in time this holiday.